MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies _ Alzheimers & Dementia
Cognition Therapeutics, Inc. (NASDAQ: CGTX)*
Organization & Developments: Cognition
Parents
Cognition Therapeutics, Inc. (NASDAQ: CGTX)*
Children
*Cognition Therapeutics, Inc. is a leader in the discovery and development of small molecule therapeutics targeting the toxic proteins that cause the cognitive decline associated with Alzheimer's disease and other degenerative diseases
*Drug discovery company developing novel, small molecule disease-modifying treatments for Alzheimer's
2025: Cognition: Zervimesine AD Treatment Program FDA Alignment Means "Strong Buy" Rating
Jumps
*Key People: Cognition
Finance & Acquisitions: Cognition